Buy Lemon Tree Hotels, target price Rs 174: ICICI Securities


ICICI Securities has a buy call on Lemon Tree Hotels with a target price of Rs 174. The current market price of Lemon Tree Hotels is Rs 141.3. Lemon Tree Hotels. incorporated in 1992, is a Mid Cap company with a market cap of Rs 11188.90 crore, operating in the Tourism & Hospitality sector.

Lemon Tree Hotels’ key products/revenue segments include Income from Rooms, Restaurants & Other Services and Other Operating Revenue for the year ending 31-Mar-2024.

Financials
For the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 379.40 crore, up 6.63% from last quarter Total Income of Rs 355.80 crore and up 13.65 % from last year same quarter Total Income of Rs 333.84 crore. The company has reported net profit after tax of Rs 108.77 crore in the latest quarter. The company?s top management includes Mr.Patanjali Govind Keswani, Mr.Niten Malhan, Mr.Willem Albertus Hazeleger, Mr.Aditya Madhav Keswani, Ms.Freyan Jamshed Desai, Mr.Paramartha Saikia, Ms.Smita Anand, Mr.Praveen Garg, Mr.Sanjiv Nandan Sahai. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 79 crore shares outstanding.

Live Events


Investment Rationale
Lemon Tree Hotels reported Q4FY25 consolidated revenue of Rs 3.8 billion (up 15% YoY) in-line with I-Sec estimates as portfolio ARRs (including Mumbai Aurika) grew 7% YoY, while occupancy for the quarter stood at 77.6%, which increased 557bps YoY. This translated into a RevPAR of Rs 5,462, rising 15% YoY. Hence, Q4FY25 EBITDA of Rs 2 billion was up 19% YoY at a margin of 54%, which was up 154bps YoY. ICICI Securities expects the company’s net debt to reduce to ~Rs 11 billion by Mar’27E (Rs 17 billion, as of Mar’25) driven by scale-up in Aurika Mumbai ARRs to over Rs 12,000. The brokerage retains the BUY rating with an SoTP-based target price of Rs 174, based on 22x Mar?27E EV/EBITDA. Key risks are demand slowdown in occupancies and room rates.
Promoter/FII Holdings
Promoters held 22.49 per cent stake in the company as of 31-Mar-2025, while FIIs owned 20.89 per cent, DIIs 19.66 per cent.

(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.



Source link

Releated Posts

Accenture shares tank 11% despite beat in revenue estimates. Infosys ADRs fall 3%

Accenture shares fell 11% on Friday, hitting the day’s low of $273.19, notwithstanding a revenue beat for third…

ByAjay jiJun 20, 2025

Biocon raises Rs 4,500 crore through successful QIP

Biocon completed an equity fundraising of Rs 4,500 crore through qualified institutional placement (QIP), the country’s leading biopharmaceutical…

ByAjay jiJun 20, 2025

No obstacle will remain in NSE IPO: Sebi Chairman Tuhin Kanta Pandey

Mumbai, Sebi chairman Tuhin Kanta Pandey on Friday affirmed that no obstacle will remain for the country’s largest…

ByAjay jiJun 20, 2025

Vishal Mega Mart block deal: US asset manager Vanguard buys stake worth Rs 655 crore

One of the world’s largest asset managers Vanguard on Friday executed two large block deals in Vishal Mega…

ByAjay jiJun 20, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *

Exit mobile version